SCHEDULE 13G: GENETRONICS BIOMEDICAL/J&J

Company

JOHNSON & JOHNSON

Filed

March 21, 2001

Accession Number

0000950123-01-002485

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →